27.86

0.00% 0.00

Scholar Rock Holding Corp (SRRK)

Overview News Price History Option Chain Financials Discussions Forecast

Scholar Rock Holding Corp stock is traded at $27.86, with a volume of 662.41K. It is up +0.00% in the last 24 hours and down -8.81% over the past month. Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Previous Close:

$27.86

Open:

$27.98

24h Volume:

662.41K

Relative Volume:

0.36

Market Cap:

$2.61B

Revenue:

$47.30M

Net Income/Loss:

$-203.85M

P/E Ratio:

-14.14

EPS:

-1.97

Net Cash Flow:

$-168.65M

1W Performance:

+1.75%

1M Performance:

-8.81%

6M Performance:

+122.52%

1Y Performance:

+137.11%

1-Day Range:

$27.36

$28.30

1-Week Range:

$25.75

$28.30

52-Week Range:

$6.76

$35.38

Scholar Rock Holding Corp Stock (SRRK) Company Profile

Name

Scholar Rock Holding Corp

Sector

Healthcare (1193)

Industry

Biotechnology (683)

Phone

857-259-3860

Address

301 BINNEY STREET, CAMBRIDGE, MA

Employee

150

Twitter

@ScholarRock

Next Earnings Date

2024-11-12

Latest SEC Filings

SRRK's Discussions on Twitter

Compare SRRK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SRRK	27.86	2.61B	47.30M	-203.85M	-168.65M	-1.97
VRTX	451.23	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	743.35	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	591.82	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.79	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.14	24.49B	3.30B	-501.07M	1.03B	11.54

Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-03-23	Resumed	Piper Sandler	Overweight
Sep-19-22	Resumed	H.C. Wainwright	Buy
Jul-12-22	Initiated	Truist	Buy
Mar-23-22	Initiated	H.C. Wainwright	Buy
Dec-22-21	Downgrade	Jefferies	Buy → Hold
Nov-19-21	Initiated	Piper Sandler	Overweight
Apr-26-21	Resumed	Credit Suisse	Outperform
Jan-11-21	Initiated	Credit Suisse	Outperform
Jan-06-21	Initiated	JP Morgan	Overweight
Mar-12-20	Initiated	Robert W. Baird	Outperform

View All

Scholar Rock Holding Corp Stock (SRRK) Latest News

Nov 16, 2024

Scholar Rock chief medical officer sells $63k in stock By Investing.com - Investing.com Australia

Nov 14, 2024

Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World

Nov 14, 2024

Nov 13, 2024

Scholar Rock chief medical officer sells $63k in stock - Investing.com

Nov 13, 2024

Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Creative Planning Invests $115,000 in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World

Nov 13, 2024